Torrent Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Torrent Pharma - Not Just Healthcare But Lifecare
One of their notable products is ROFLUMILAST, with a corresponding US DMF Number 35661.
Remarkably, this DMF maintains an Active status since its submission on March 11, 2021, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 21, 2021, and payment made on March 04, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II